Recommendations for evaluating the validity of quality of life claims for labeling and promotion.
about
Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux diseaseThe influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazolePatient-reported outcome and quality of life instruments database (PROQOLID): frequently asked questionsPatient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastasesEffects of Multidrug Resistant Tuberculosis Treatment on Patients' Health Related Quality of Life: Results from a Follow Up StudyRare inborn errors of metabolism with movement disorders: a case study to evaluate the impact upon quality of life and adaptive functioningInconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialistsEMEA and the evaluation of health-related quality of life data in the drug regulatory process.Current practices in patient-reported outcome (PRO) data collection in clinical trials: a cross-sectional survey of UK trial staff and managementA review of patient-reported outcome measures to assess female infertility-related quality of life.Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the inhaled insulin treatment questionnaire (IITQ)Defining health-related quality of life for young wheelchair users: A qualitative health economics study.The effect of beta-blockers on health-related quality of life in patients with heart failure.The Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS) Questionnaire: item reduction and further validation.Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials.Patient-reported outcome (PRO) assessment in clinical trials: a systematic review of guidance for trial protocol writersWeight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment.Health-related quality of life and gastrointestinal disease.Patient reported outcomes (PROs) in clinical trials: is 'in-trial' guidance lacking? a systematic review.The effect of phytosterols on quality of life in the treatment of benign prostatic hyperplasia.Responsiveness and minimal important differences for patient reported outcomes.The quality of life of children with attention deficit/hyperactivity disorder: a systematic review.Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes.The FDA guidance for industry on PROs: the point of view of a pharmaceutical companyPatient-reported outcomes (PRO's) in glaucoma: a systematic reviewThe case for considering quality of life in addiction research and clinical practicePsychometric properties of the quality of life scale Child Health and Illness Profile-Child Edition in a combined analysis of five atomoxetine trials.Development and validation of a disease-specific treatment satisfaction questionnaire for gastro-oesophageal reflux disease.Health-related quality of life assessment in adult haemophilia patients: a systematic review and evaluation of instruments.Patient assessment of treatment satisfaction: methods and practical issuesAssessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.Quantifying the importance of disease burden on perceived general health and depressive symptoms in patients within the Mayo Clinic Biobank.Prospective patterns and correlates of quality of life among women in substance abuse treatment.Technology dependence and health-related quality of life: a model.Validation of two generic patient-reported outcome measures in patients with type 2 diabetesAssessing functional health status in adults with haemophilia: towards a preliminary core set of clinimetric instruments based on a literature search in Rheumatoid Arthritis and Osteoarthritis.Measuring patient experiences in Fabry disease: validation of the Fabry-specific Pediatric Health and Pain Questionnaire (FPHPQ).Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment.Workshop Report: concepts and methods in the economics of nutrition--gateways to better economic evaluation of nutrition interventions.Psychometric assessment of the Injection Pen Assessment Questionnaire (IPAQ): measuring ease of use and preference with injection pens for human growth hormone
P2860
Q24791343-BB02D221-512E-44D2-93C8-8B4A5672E2E0Q24791577-ADF26BFF-8750-419E-BD28-C378A2E0BCE2Q24806407-05154D3A-B9F0-4D44-8302-9E7DD5C9DA40Q26997330-CD61CADF-7F40-4488-AAC8-5A43A9B231DCQ28553181-8BBCF229-8571-4E33-A642-5E258A2BA7E7Q30604557-D972B14A-EE6D-410C-89DD-6DE1CAFA13FEQ30677410-46DC188E-3D3F-4B73-9942-4D6820F36C2EQ30965669-DA494986-A7DA-46A3-9372-C5CD37476D5FQ31134502-54B2B7DB-4C14-4CF9-ABBE-99B70F10704EQ33613023-40B717EE-93B5-4E79-A35A-3A3E62F29625Q33797394-2B153B5C-17CC-48A3-83BA-EE6D8F64DBAEQ33803230-83CEBFDB-1EC6-4401-AF12-372CCB6B7A07Q33942862-BE8DE365-F7B4-4241-AEF3-20CC198AFE1DQ34294970-BCC8BFD3-3CB2-4B6F-B196-4E966C4C68A8Q34337012-AC229FC3-C4A0-436A-B89A-E04481750227Q34344385-4AB9BF09-4D8A-462B-8770-E10AEAA71656Q34507074-D604314C-3465-49AD-93C5-B49CFCD5A767Q34631350-47934F62-750A-4E44-B50B-B2AB19D0EC93Q34656446-69580691-4F65-4C69-A6A2-9E3FF728A93CQ34998083-645F2107-7CD5-415A-8CB3-09F61F4BD2E3Q35062340-F7E35788-2ACE-4BDB-80DE-B339E5264C75Q35084047-1F95D0AE-C335-47BE-ACD4-0B266F6C523AQ35126645-8A6F80B0-162C-46FF-BB88-0FE4E5B188C5Q35129599-5FA5D8FB-8AC8-453D-AC66-8D8A7D3FD29DQ35208797-36B4822F-D763-4ADF-814B-1AACF6983C6FQ35286364-9FE267AD-E4B7-461C-8CFC-77865636AD8AQ35563516-F535A10D-AC99-4ED1-96AE-00A75C5FE7CAQ35583055-3D3CEBA9-19B6-49A1-B963-108F82F5D4D9Q35642571-125E46FB-4F2A-4B41-BC34-07199202AA99Q35745046-40F990C9-956D-4C3C-B408-0EC375E72979Q35775301-4ADDB836-40D5-4F85-9BC1-026437B378ACQ35814338-17B222DE-A0C5-406F-9EED-2294D1C1DB1AQ36004509-D97E2776-8910-4602-9A9B-16611538F14FQ36078851-92275790-8789-419F-807C-1DD2C4CE18C6Q36093328-C4A41A61-218E-4F4D-90A2-1321B26518C4Q36191209-EDA18A46-4390-4261-990C-DA403EE809ECQ36367945-8ACDDC39-B5D9-4C52-BDA0-747F2C9871FCQ36402620-55DF80E1-9E77-4C52-8F3B-E1B9D47A0666Q36443118-320E2E80-D7A0-4615-AA95-48B8C3E57ADBQ36459466-27EBAA5D-DA55-4382-81D7-FAD83B2BCF4E
P2860
Recommendations for evaluating the validity of quality of life claims for labeling and promotion.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Recommendations for evaluating ...... ms for labeling and promotion.
@en
type
label
Recommendations for evaluating ...... ms for labeling and promotion.
@en
prefLabel
Recommendations for evaluating ...... ms for labeling and promotion.
@en
P2093
P1433
P1476
Recommendations for evaluating ...... ms for labeling and promotion.
@en
P2093
P304
P356
10.1046/J.1524-4733.1999.02210.X
P577
1999-03-01T00:00:00Z